Dec 11, 2013The Anticipated Clinical Effect of the new AD Drug ANAVEX 2-73 in a Calibrated Quantitative SystemsCNS Summit 2013, Boca Raton, FLChristopher Missling, Tangui Maurice, Athan Spiros, Patrick Roberts and Hugo GeertsView Poster
CNS Summit 2013, Boca Raton, FLChristopher Missling, Tangui Maurice, Athan Spiros, Patrick Roberts and Hugo GeertsView Poster
Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA
Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal